Marshall Stoller, MD

Urologist

Dr. Marshall L. Stoller is medical director of the Urinary Stone Center at UCSF Medical Center that provides care for urinary stone disease including minimally invasive techniques or techniques requiring only small incisions such as endourology and laparoscopy. Stoller has helped spearhead a comprehensive program in the management of urinary stone disease, utilizing and testing a variety of lithotriptors, a non-invasive device that pulverizes urinary stones. Stoller is certified by the American Board of Urology. He has received many awards, including grand prize in the annual Lapides Essay Contest in Urodynamic and Neurourology Research.

Stoller graduated from the University of California at Berkeley in 1976 and went to medical school at Baylor College of Medicine in Houston, Texas. After medical school, he returned to the Bay Area, where he was a general surgical intern and resident and a urology resident at the University of California, San Francisco from 1981 to 1985. The following year, he became a clinical instructor and research fellow at the University of New South Wales at Prince Henry and Prince of Wales Hospitals in Sydney, Australia. Stoller returned to UCSF as chief resident in urology and then joined the medical staff. He is a professor in residence in urology and has received the Distinction in Teaching Award from the Academic Senate at UCSF.

For more information about his research, please visit Stoller’s lab website at http://stollerlab.ucsf.edu.

Clinics

Urology Practice
400 Parnassus Ave., Sixth Floor, Suite A610
San Francisco, CA 94143
Phone: (415) 353-2200
Fax: (415) 353-2641

Hours: Monday to Friday
8 a.m. – 5 p.m.

Board Certification

Urology, American Board of Urology

Academic Title

Professor

More about Marshall Stoller

Education

Baylor College of Medicine 1981

Residencies

UCSF Medical Center, Urology 1987

Selected Research and Publications

  1. Tzou DT, Caldwell C, Simko JP, Chi T, Stoller ML. Management of Inverted Papilloma during Holmium Laser Enucleation of Prostate (HoLEP). Urology. 2018 Mar 12.
  2. Sherer BA, Chen L, Kang M, Shimotake AR, Wiener SV, Chi T, Stoller ML, Ho SP. A continuum of mineralization from human renal pyramid to stones on stems. Acta Biomater. 2018 Feb 09.
  3. Taguchi K, Usawachintachit M, Tzou DT, Sherer BA, Metzler I, Isaacson D, Stoller ML, Chi T. Micro-Costing Analysis Demonstrates Comparable Costs for LithoVue Compared to Reusable Flexible Fiberoptic Ureteroscopes. J Endourol. 2018 Jan 12.
  4. May PC, Hsi RS, Tran HH, Stoller M, Chew BH, Chi T, Usawachintachit M, Duty BD, Gore JL, Harper JD. The Morbidity of Ureteral Strictures in Patients with Prior Ureteroscopic Stone Surgery: Multi-Institutional Outcomes. J Endourol. 2018 Jan 12.
  5. Usawachintachit M, Sherer B, Hudnall M, Tzou DT, Taguchi K, Hsi RS, Stoller M, Chi T. Clinical Outcomes for Cystinuria Patients with Unilateral Versus Bilateral Cystine Stone Disease. J Endourol. 2018 Feb; 32(2):148-153.
  6. Taguchi K, Harper JD, Stoller ML, Duty BD, Sorensen MD, Sur RL, Usawachintachit M, Tzou DT, Wenzler DL, Isaacson D, Xu A, Chu C, Zaid UB, Taylor ER, Ramaswamy K, Chi T. Identifying factors associated with need for flexible ureteroscope repair: a Western Endourology STone (WEST) research consortium prospective cohort study. Urolithiasis. 2017 Dec 09.
  7. Chen L, Hsi RS, Yang F, Sherer BA, Stoller ML, Ho SP. Anatomically-specific intratubular and interstitial biominerals in the human renal medullo-papillary complex. PLoS One. 2017; 12(11):e0187103.
  8. Isaacson D, Ahmad T, Metzler I, Tzou DT, Taguchi K, Usawachintachit M, Zetumer S, Sherer B, Stoller M, Chi T. Defining the Costs of Reusable Flexible Ureteroscope Reprocessing Using Time-Driven Activity-Based Costing. J Endourol. 2017 Oct; 31(10):1026-1031.
  9. Graves CE, Co C, Hsi RS, Kwiat D, Imamura-Ching J, Harrison MR, Stoller ML. Magnetic Compression Anastomosis (Magnamosis): First-In-Human Trial. J Am Coll Surg. 2017 Nov; 225(5):676-681.e1.
  10. Bose N, Zee T, Kapahi P, Stoller ML. Mass Spectrometry-based in vitro Assay to Identify Drugs that Influence Cystine Solubility. Bio Protoc. 2017 Jul 20; 7(14).
  11. Killilea DW, Chow D, Xiao SQ, Li C, Stoller ML. Flame retardant tris(1,3-dichloro-2-propyl)phosphate (TDCPP) toxicity is attenuated by N-acetylcysteine in human kidney cells. Toxicol Rep. 2017; 4:260-264.
  12. Usawachintachit M, Isaacson DS, Taguchi K, Tzou DT, Hsi RS, Sherer BA, Stoller ML, Chi T. A Prospective Case-Control Study Comparing LithoVue, a Single-Use, Flexible Disposable Ureteroscope, with Flexible, Reusable Fiber-Optic Ureteroscopes. J Endourol. 2017 May; 31(5):468-475.
  13. Wang RC, Addo N, Chi T, Moore C, Mallin M, Shiboski S, Stoller M, Smith-Bindman R. Medical expulsive therapy use in emergency department patients diagnosed with ureteral stones. Am J Emerg Med. 2017 Aug; 35(8):1069-1074.
  14. Zee T, Bose N, Zee J, Beck JN, Yang S, Parihar J, Yang M, Damodar S, Hall D, O'Leary MN, Ramanathan A, Gerona RR, Killilea DW, Chi T, Tischfield J, Sahota A, Kahn A, Stoller ML, Kapahi P. a-Lipoic acid treatment prevents cystine urolithiasis in a mouse model of cystinuria. Nat Med. 2017 Mar; 23(3):288-290.
  15. Mellema M, Stoller M, Queau Y, Ho SP, Chi T, Larsen JA, Passlack N, Fascetti AJ, Mohr C, Westropp JL. Nanoparticle Tracking Analysis for the Enumeration and Characterization of Mineralo-Organic Nanoparticles in Feline Urine. PLoS One. 2016; 11(12):e0166045.
  16. Hsi RS, Stoller ML. Complete Metabolic Evaluation is Indicated after a First Stone Event: Con. J Urol. 2017 Mar; 197(3 Pt 1):545-547.
  17. Tasian GE, Ross ME, Song L, Grundmeier RW, Massey J, Denburg MR, Copelovitch L, Warner S, Chi T, Killilea DW, Stoller ML, Furth SL. Dietary Zinc and Incident Calcium Kidney Stones in Adolescence. J Urol. 2017 May; 197(5):1342-1348.
  18. Tzou DT, Taguchi K, Chi T, Stoller ML. Animal models of urinary stone disease. Int J Surg. 2016 Dec; 36(Pt D):596-606.
  19. Chang HC, Tzou DT, Usawachintachit M, Duty BD, Hsi RS, Harper JD, Sorensen MD, Stoller ML, Sur RL, Chi T. Rationale and Design of the Registry for Stones of the Kidney and Ureter (ReSKU): A Prospective Observational Registry to Study the Natural History of Urolithiasis Patients. J Endourol. 2016 12; 30(12):1332-1338.
  20. Metzler IS, Smith-Bindman R, Moghadassi M, Wang RC, Stoller ML, Chi T. Emergency Department Imaging Modality Effect on Surgical Management of Nephrolithiasis: A Multicenter, Randomized Clinical Trial. J Urol. 2017 Mar; 197(3 Pt 1):710-714.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.